$CTVA

Capital World Investors (NYSE: CTVA) reports 6.6% ownership stake in Corteva

Capital World Investors, a Capital Research and Management affiliate, filed a beneficial ownership report for Corteva, Inc. It says it holds 43,841,218 shares, or 6.6% of 667,018,000 shares outstanding as of June 30, 2026. The filing lists sole voting power over 43,417,923 shares and sole dispositive power over 43,841,218 shares.

Original reporting
Published Aug 12, 2026, 9:41 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 13, 2026, 4:53 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CTVA
Neutral
medium confidence
Mentioned
$CTVA
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CTVANeutralLow
01

Why it matters

Traders may monitor for subsequent filings (13D/13G amendments), board/strategy signals, or additional stake changes, but the provided text alone does not indicate immediate fundamental catalysts.

02

Market read

A fresh beneficial ownership disclosure (6.6%) can influence positioning and governance narratives, but the article contains no operational or financial developments.

03

What to watch

The filing does not state whether the stake is newly accumulated versus previously held, nor does it describe any activist agenda, which limits conviction on follow-through.

Relevance 4/10Novelty 5/10Timing: ownership filing reported on 2026-08-12

Background

The article summarizes a beneficial ownership report by Capital World Investors for Corteva, including share count and voting/dispositive power.

Company-level read

Ticker impact

$CTVANeutralMedium confidence
Context

Capital World Investors disclosed a 6.6% beneficial ownership stake in Corteva, totaling 43,841,218 shares as of June 30, 2026.

Expected impact

Likely limited near-term impact; any move would be sentiment/positioning-driven rather than fundamentals.

Evidence & confidence

The article is a beneficial ownership filing summary (shares, voting power, dispositive power) with no accompanying guidance, deal, or regulatory action. Such disclosures can matter for longer-horizon activism or control narratives, but the text provides no activist intent or follow-on event.

Market effects

Minimal, since the disclosure is company-specific and does not describe sector-wide catalysts.

Minimal, as it is a US-listed single-name ownership update.

Low, no cross-border transaction or global regulatory action is described.

Counterpoint

A disclosed 6.6% stake may be largely passive and not translate into near-term changes, so trading impact could be overstated.

Key entities

  • Capital World Investors

    Reported beneficial owner of 43,841,218 Corteva shares, representing 6.6% of the class.

  • Corteva, Inc.

    US-listed company (CTVA) whose beneficial ownership structure was disclosed via the filing summary.

Related articles

$DDMed

California alleges DuPont used spin-off companies to avoid PFAS liability

California Attorney General Rob Bonta alleges in a federal filing that DuPont and three spin-offs used memorandums of understanding to shift most PFAS liabilities onto Chemours while limiting exposure for Corteva, New DuPont and Qnity. Bonta cites possible fraudulent transfer law violations. DuPont disputes; a prior New Jersey case settled for $2 billion.

$CTVAMed

Romania Fines Seed and Crop-Protection Firms $18 Million

Romania’s Competition Council fined seed and crop-protection firms about $18 million total for resale-price arrangements. SeeNews said Pioneer Hi-Bred Romania, Corteva Crop Solutions and Maisadour Semences Romania used contractual terms and a voucher program to set resale prices during agricultural campaigns. Agrii received 17.9 million lei; 15 of 21 firms admitted violations, and Agricover received leniency.

$CTVAMedAI 8/10

Corteva (CTVA) Q2 2026 Earnings Call Transcript

Corteva (CTVA) reported first-half 2026 net sales of $11.3B (+4%), operating EBITDA of $3.7B (+10%), and operating EPS of $3.80 (+14%). FY2026 operating EBITDA guidance was raised to $4.1B-$4.3B and operating EPS to $3.60-$3.80. Management cited strong seed demand, new crop protection volumes, and separation costs.

$CTVAMed

Corteva’s Vylor launches note exchange ahead separation

Corteva (CTVA) said its seed unit Vylor launched private exchange offers and consent solicitations for EIDP, Inc. senior notes due 2030, 2032 and 2033. Up to $1.6 billion of notes would be swapped for new Vylor notes, tied to Corteva’s planned separation into two listed companies around Oct. 1, 2026. Offers require separation completion and majority consents to amend covenants. Vylor also set new credit facilities totaling $5.58 billion and expects about $1.1 billion cash at separation.

$DDMedAI 8/10

New Jersey Judge Approves $2.5 Billion PFAS Settlements With DuPont and 3M

A New Jersey federal judge approved PFAS settlements totaling over $2.5 billion with DuPont, Chemours, Corteva and 3M, Reuters reported. The deals require cleanup of four former sites and compensation for natural-resource damages, including a $1.2 billion restoration fund. DuPont, Chemours and Corteva pay $875 million over 25 years; 3M pays $400-$450 million, plus a $475 million reserve.